Navigation Links
Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®
Date:3/15/2012

PITTSBURGH and TORONTO, March 15, 2012 /PRNewswire/ -- Mylan Pharmaceuticals ULC, the Canadian subsidiary of Mylan Inc. (NASDAQ: MYL), today received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg. Mylan-Rosuvastatin is the generic version of Astra Zeneca's Crestor® Tablets, which are used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia.  According to IMS Health, Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg, had Canadian sales of approximately $742 million for the 12 months ending Dec. 31, 2011.

"We are very pleased to introduce Mylan-Rosuvastatin to the Canadian market," said Dick Guest, president of Mylan Canada. "According to the Canadian Heart and Stroke Foundation, 'about 40% of Canadians have high blood cholesterol.'[1] Not only does this introduction provide Canadians with access to our quality medicine, it does so at a substantially lower cost. The introduction of generic medicines like Mylan-Rosuvastatin helps to contribute to a sustainable health care system."

Currently, Mylan Canada has 42 product applications pending Health Canada approval representing $3.6 billion in annual sales, according to IMS Health.

In Canada, generic drugs cost consumers an average of 60% less than their brand name counterparts. 

Mylan-Rosuvastatin is contraindicated in patients who are hypersensitive to it and in patients with active liver disease.  Pregnant women or women wishing to become pregnant should not take Rosuvastatin, as well as patients taking cyclosporine.

About Mylan
Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan in Canada, please visit www.mylan.ca. For more information about generic drugs, please visit www.ChoosingGenerics.ca.

[1] http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483991/k.34A8/Statistics.htm  


'/>"/>
SOURCE Mylan Pharmaceuticals ULC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 2016 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: ... R&D program in the use of cannabinoids for ... In June, 2015 InMed initiated its COPD program ... targets and potential active compounds that can be ... in vitro assays using human lung fibroblasts (HFL-1 ...
(Date:12/6/2016)... Dec. 6, 2016  In response to the tragic ... every 25 minutes, a respected group of local and ... provide a holistic suite of services to help Medicaid-eligible ... on his own experience trying to help family and ... Justin Lanning launched 180 Health Partners ...
(Date:12/5/2016)... YORK , Dec. 5, 2016  Balloon catheter ... catheter, which is inserted into the femoral artery in ... the arm to treat constricted blood vessels. These products ... due to atherosclerosis – deposition of lipid substances in ... balloon catheter market is projected to expand at a ...
Breaking Medicine Technology:
(Date:12/6/2016)... GA (PRWEB) , ... December 06, 2016 , ... ... of largest patient satisfaction measurement firms. The ranking is based on reported ... organizations such as hospitals, health systems, ambulatory surgical centers, clinically integrated networks, and ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health Center ... recognizing the organization as a top behavioral service provider in the country. The ... quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured via ...
(Date:12/6/2016)... ... ... Just in time for the holiday season, the celebrated paleo and gluten-free ... new Organic Quinoa Flour product for sale at Costco stores throughout the northwest region ... “I think it’s wonderful that a growing number of retailers such as Costco are ...
(Date:12/6/2016)... ... 06, 2016 , ... Keeping Gift Season Safe, In a season stacked with ... age-appropriate for their recipients. This is the idea behind Safe Toys and Gifts Month, ... that would make good gifts for children. For companies that produce goods that fall ...
(Date:12/6/2016)... ... December 06, 2016 , ... "Add realistic flares and light leaks ... flare from clip to clip with high quality 4K lens flare footage," said Christina ... 44 lens flares filmed on the RED Dragon. Utilizing the Dragon Sensor, TransFlare 4K ...
Breaking Medicine News(10 mins):